![Robert Gagnon](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Robert Gagnon
Director of Finance/CFO at
OPUS GENETICS, INC.
Net worth: 3 M $ as of 31/05/2026
Profile
Robert E.
Gagnon is Secretary, Treasurer & Director at KD Scientific, Inc. He is Independent Director at Harvard Bioscience, Inc. starting in 2025, Independent Director at Purple Biotech Ltd. since 2021, Independent Director at Bone Biologics Corp.
since 2024, and Chief Financial & Accounting Officer at Opus Genetics, Inc. starting in 2025.
Former roles include Director at Verastem, Inc. from 2022 to 2026, Chief Financial Officer, Treasurer & Executive VP at Clean Harbors, Inc. from 2012 to 2013, CAO, VP-Business Planning & Controller at Biogen, Inc. in 2012, Chief Financial Officer at Harvard Bioscience, Inc. from 2015 to 2018, Chief Financial & Business Officer at Verastem, Inc. from 2019 to 2022, Partner at Gurnet Point Capital LLC from 2022 to 2023, Chief Financial Officer at Remix Therapeutics, Inc. from 2023 to 2025, and Manager-Global Orthobiologics R&D at Zimmer Biomet, Inc. from 2013 to 2017.
Education includes undergraduate studies at Bentley University and an MBA from MIT Sloan School of Management.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
OPUS GENETICS, INC. 0.73% | 23/04/2026 | 592,158 ( 0.73% ) | 3 M $ | 31/05/2026 |
VERASTEM, INC. 0.07% | 24/03/2026 | 41,678 ( 0.07% ) | 180 466 $ | 31/05/2026 |
| 09/06/2026 | 11,000 ( 0.24% ) | 64 680 $ | 31/05/2026 | |
PURPLE BIOTECH LTD. 0.15% | 18/03/2026 | 3,062,500 ( 0.15% ) | 10 933 $ | 31/05/2026 |
BONE BIOLOGICS CORP. -.--% | 23/02/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
Robert Gagnon active positions
| Companies | Position | Start |
|---|---|---|
| PURPLE BIOTECH LTD | Director/Board Member | 03/03/2021 |
| BONE BIOLOGICS CORPORATION | Director/Board Member | 08/01/2024 |
| HARVARD BIOSCIENCE, INC. | Director/Board Member | 16/07/2025 |
| OPUS GENETICS, INC. | Director of Finance/CFO | 02/09/2025 |
KD Scientific, Inc.
 KD Scientific, Inc. Medical SpecialtiesHealth Technology Develops and manufactures syringe pumps used by research laboratory markets globally | Director/Board Member | - |
Former positions of Robert Gagnon
| Companies | Position | End |
|---|---|---|
| VERASTEM, INC. | Director/Board Member | 21/05/2026 |
Remix Therapeutics, Inc.
 Remix Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company develops molecule therapies to modulate RNA processing and address the underlying drivers of diseases | Director of Finance/CFO | 30/06/2025 |
Gurnet Point Capital LLC
 Gurnet Point Capital LLC Investment ManagersFinance Gurnet Point Capital invests in companies located in the United States. The firm targets companies operating in the fields of life sciences and medical technologies sector. It provides financing for buyout stage capital requirements. It also acquires majority stake and control positions. | Corporate Officer/Principal | 01/06/2023 |
| VERASTEM, INC. | Director of Finance/CFO | 31/10/2022 |
| ░░░░░░░ ░░░░░░░░░░░ ░░░░ | ░░░░░░░░ ░░ ░░░░░░░░░░░ | ░░░░░░░░░░ |
Training of Robert Gagnon
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
55
1st degree connections
13
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 13 |
|---|---|
Clean Harbors, Inc.
 Clean Harbors, Inc. Environmental ServicesIndustrial Services Provides environmental and industrial waste recycling services | Industrial Services |
Biogen, Inc.
 Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Harvard Bioscience, Inc.
 Harvard Bioscience, Inc. Medical SpecialtiesHealth Technology Manufactures, develops and markets apparatus and scientific instruments | Health Technology |
KD Scientific, Inc.
KD Scientific, Inc. Medical SpecialtiesHealth Technology Develops and manufactures syringe pumps used by research laboratory markets globally | Health Technology |
Bentley University
 Bentley University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Verastem, Inc.
 Verastem, Inc. BiotechnologyHealth Technology Discovers and develops drugs | Health Technology |
Purple Biotech Ltd.
 Purple Biotech Ltd. Pharmaceuticals: MajorHealth Technology Provides pharmaceutical drug discovery and development services | Health Technology |
MIT Sloan School of Management
 MIT Sloan School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bone Biologics Corp.
 Bone Biologics Corp. Medical SpecialtiesHealth Technology Develops ortho biologic products | Health Technology |
Gurnet Point Capital LLC
Gurnet Point Capital LLC Investment ManagersFinance Gurnet Point Capital invests in companies located in the United States. The firm targets companies operating in the fields of life sciences and medical technologies sector. It provides financing for buyout stage capital requirements. It also acquires majority stake and control positions. | Finance |
Remix Therapeutics, Inc.
Remix Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company develops molecule therapies to modulate RNA processing and address the underlying drivers of diseases | Health Technology |
Ocuphire Pharma, Inc.
 Ocuphire Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceuticals for eye disorders | Health Technology |
Zimmer Biomet, Inc. |
- Stock Market
- Insiders
- Robert Gagnon
